1. Market Research
  2. > All Companies
  3. > Allergan, Inc. (AGN) - Medical Equipment - Deals and Alliances Profile

Summary

Allergan, Inc. (Allergan) is a global healthcare company. It develops and commercializes novel pharmaceuticals, over-the-counter products, biologics and the medical devices addressing ophthalmic, neurological, medical aesthetic, medical dermatology, breast aesthetic, urological, and other specialty markets. The company’s research and development efforts focus on products and technologies related to wide range of specialty areas with significant unmet clinical needs. The company sells its products through a network of own distributors and direct subsidiaries in approximately 40 countries and through independent distributors in about 100 countries across the world. The major customers of the company include wholesalers, drug stores, pharmacies, opticians, merchandisers, food stores, hospitals, and medical practitioners among others. Allergan is headquartered in Irvine, California, the US.

Allergan, Inc. (AGN) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table Of Contents

Allergan, Inc. (AGN) - Medical Equipment - Deals and Alliances Profile
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Allergan, Inc., Medical Equipment, Deals By Year, 2009 to YTD 2015 6
Allergan, Inc., Medical Equipment Deals By Type, 2009 to YTD 2015 7
Allergan, Inc., Medical Equipment, Deals By Region, 2009 to YTD 2015 8
Allergan, Inc., Medical Equipment, Deals By Market, 2009 to YTD 2015 9
Allergan, Inc., Medical Equipment, Deals Summary, 2009 to YTD 2015 10
Allergan, Inc., Medical Equipment, Deal Details 11
Asset Purchase 11
Allergan Acquires Aline Hyaluronic Acid Thread Technology From Aline Aesthetics 11
Allergan Acquires Distribution Business In Turkey For US$36.7 Million 12
Venture Financing 13
Colorescience Raises USD15 Million in Series B Venture Financing 13
Colorescience Raises US$10 Million In Series A Financing 14
Colorescience Raises US$15 Million In Venture Financing 16
SkinMedica Secures US$9.4 Million In Financing 17
Colorescience Raises US$1.5 Million In Venture Financing 18
Private Equity 19
VMG Partners Invests In Colorescience 19
BTG Enters Into Licensing Agreement With Allergan 20
Debt Offering 21
Allergan Completes Public Offering Of Senior Unsecured Notes Due 2020 For US$650 Million 21
Asset Transactions 23
Apollo Endosurgery Completes Acquisition Of Obesity Intervention Division Of Allergan For Up To US$110 Million 23
Acquisition 25
Actavis Acquires Allergan for USD70.5 Billion 25
SkinMedica Acquires Colorescience, Maker Of Skincare Products 27
Allergan Acquires Precision Light For US$17.9 Million 28
Allergan Completes Acquisition Of Alacer Biomedical 29
Allergan Completes Acquisition Of Serica Technologies 30
Allergan, Inc. - Key Competitors 32
Key Employees 33
Locations And Subsidiaries 34
Head Office 34
Other Locations and Subsidiaries 34
Recent Developments 38
Strategy And Business Planning 38
Nov 12, 2014: Allergan Board of Directors Announces Approval of Amendments to Company's Bylaws 38
Financial Announcements 39
Oct 27, 2014: Allergan Reports Third Quarter 2014 Operating Results 39
Jul 21, 2014: Allergan Reports Second Quarter 2014 Operating Results 41
May 07, 2014: Allergan Reports First Quarter 2014 Operating Results 44
Feb 05, 2014: Allergan Reports Fourth Quarter 2013 Operating Results 46
Corporate Communications 48
Oct 17, 2014: Allergan To Lay Off 40 Employees In Carlsbad, California 48
Sep 12, 2014: Allergan Announces Workforce Reduction 49
Aug 18, 2014: Allergan Names Jim Hindman Chief Financial Officer 50
Jun 02, 2014: Allergan Comments on Pershing Square's and Valeant's Attempt to Remove a Majority of the Members of the Allergan Board of Directors 51
Legal and Regulatory 52
Dec 17, 2014: COTCHETT, PITRE and McCARTHY Files Class Action Lawsuit on Behalf of Persons Who Sold Allergan Stock Between February 25, 2014 and April 21, 2014 52
Nov 04, 2014: Allergan Comments on California Federal Court Ruling in Insider Trading Lawsuit Against Valeant and Pershing Square 53
Aug 01, 2014: Allergan Files Lawsuit in Federal Court against Valeant and Pershing Square for Violations of Federal Securities Laws 54
Jul 21, 2014: Valeant Pharmaceuticals Contacts Quebec and U.S. Regulators About Allergan's False and Misleading Statements 56
Government and Public Interest 57
Nov 14, 2014: Physicians Continue to Voice Strong Support for Allergan via Open Letters to the Eye Care Community 57
Product News 58
Jun 04, 2015: Actavis Announces FDA Approval of NATRELLE INSPIRA Round Gel-Filled Textured Breast Implants 58
Apr 29, 2015: Allergan Selects ImageIQ as Imaging CRO for LiRIS Interstitial Cystitis Clinical Trial 59
Jan 30, 2015: Clinical Study: Improved Breast Reconstruction Outcomes with Seri Scaffold 60
Nov 12, 2014: FDA Approves New Styles of Allergan's NATRELLE 410 Highly Cohesive Anatomically Shaped Silicone-Filled Breast Implants 61
Oct 29, 2014: Allergan Canada Launches a 3D JUVEDERM Visualization iPad App Powered by ModiFace 62
Sep 29, 2014: Allergan Announces FDA Approves Revised Indication for OZURDEX (dexamethasone intravitreal implant) 0.7 mg for the Treatment of Diabetic Macular Edema 63
May 29, 2014: Newport Beach Dermatologist Offers Latest Allergan Dermal Filler JUVÉDERM VOLUMA XC 64
Mar 11, 2014: Natrelle 410 Gel Breast Implants Offer Unique Advantages, Says Los Angeles Plastic Surgeon 65
Feb 06, 2014: Manhattan Plastic Surgeon Reveals Unique Benefits of JUVEDERM VOLUMA XC 66
Jan 23, 2014: Virginia Plastic Surgeon Adopts Innovative New Dermal Filler 67
Jan 22, 2014: FDA Approved Juvederm Voluma is the Newest Anti Aging Dermal Filler 68
Product Approvals 69
Jun 04, 2015: Actavis Announces FDA Approval of NATRELLE INSPIRA Round Gel-Filled Textured Breast Implants 69
Nov 12, 2014: FDA Approves New Styles of Allergan's NATRELLE 410 Highly Cohesive Anatomically Shaped Silicone-Filled Breast Implants 70
Sep 29, 2014: Allergan Announces FDA Approves Revised Indication for OZURDEX (dexamethasone intravitreal implant) 0.7 mg for the Treatment of Diabetic Macular Edema 71
Jan 22, 2014: FDA Approved Juvederm Voluma is the Newest Anti Aging Dermal Filler 72
Clinical Trials 73
Jan 30, 2015: Clinical Study: Improved Breast Reconstruction Outcomes with Seri Scaffold 73
Other Significant Developments 74
Feb 04, 2015: Allergan Reports Fourth Quarter 2014 Operating Results 74
Aug 04, 2014: Allergan RandD Innovations Recognized with Three Nominations for the 2014 U.S. Prix Galien Awards 76
Appendix 79
Methodology 79
About GlobalData 79
Contact Us 79
Disclaimer 79

List of Tables
Allergan, Inc., Medical Equipment, Key Facts, 2014 1
Allergan, Inc., Medical Equipment, Deals Summary, 2009 to YTD 2015 1
Allergan, Inc., Medical Equipment, Deals By Year, 2009 to YTD 2015 6
Allergan, Inc., Medical Equipment Deals By Type, 2009 to YTD 2015 7
Allergan, Inc., Medical Equipment, Deals By Region, 2009 to YTD 2015 8
Allergan, Inc., Deals By Market, 2009 to YTD 2015 9
Allergan, Inc., Medical Equipment, Deals Summary, 2009 to YTD 2015 10
Allergan Acquires Aline Hyaluronic Acid Thread Technology From Aline Aesthetics 11
Allergan Acquires Distribution Business In Turkey For US$36.7 Million 12
Colorescience Raises USD15 Million in Series B Venture Financing 13
Colorescience Raises US$10 Million In Series A Financing 14
Colorescience Raises US$15 Million In Venture Financing 16
SkinMedica Secures US$9.4 Million In Financing 17
Colorescience Raises US$1.5 Million In Venture Financing 18
VMG Partners Invests In Colorescience 19
BTG Enters Into Licensing Agreement With Allergan 20
Allergan Completes Public Offering Of Senior Unsecured Notes Due 2020 For US$650 Million 21
Apollo Endosurgery Completes Acquisition Of Obesity Intervention Division Of Allergan For Up To US$110 Million 23
Actavis Acquires Allergan for USD70.5 Billion 25
SkinMedica Acquires Colorescience, Maker Of Skincare Products 27
Allergan Acquires Precision Light For US$17.9 Million 28
Allergan Completes Acquisition Of Alacer Biomedical 29
Allergan Completes Acquisition Of Serica Technologies 30
Allergan, Inc., Key Competitors 32
Allergan, Inc., Key Employees 33
Allergan, Inc., Other Locations 34
Allergan, Inc., Subsidiaries 34

List of Figures
Allergan, Inc., Medical Equipment, Deals by Type, 2009 to YTD 2015 1
Allergan, Inc., Medical Equipment, Deals By Year, 2009 to YTD 2015 1
Allergan, Inc., Medical Equipment, Deals By Region, 2009 to YTD 2015 1
Allergan, Inc., Medical Equipment, Deals By Market, 2009 to YTD 2015 1
Allergan, Inc., Medical Equipment, Deals By Year, 2009 to YTD 2015 6
Allergan, Inc., Medical Equipment, Deals by Type, 2009 to YTD 2015 7
Allergan, Inc., Medical Equipment, Deals By Region, 2009 to YTD 2015 8
Allergan, Inc., Medical Equipment, Deals by Market, 2009 to YTD 2015 9

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.